Healthy high growth potential

Results

1513

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1513 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł230.90-0.3%-9.8%zł23.0bzł235.1344.729.7%0.4%Media
FWRY
ج.م19.322.4%54.6%ج.م65.8bج.م22.4524.727.3%n/aDiversified Financials
WAYS
SEK 39.601.8%-5.7%SEK 347.3mSEK 58.00210.778.5%0%Tech
KEBNI B
SEK 1.07-2.6%-60.0%SEK 292.9mSEK 1.252.690.9%n/aTech
AGP
€7.01-5.7%-7.9%€127.8m€8.5725.739.1%n/aCapital Goods
MDGL
US$546.791.8%74.5%US$12.4bUS$678.8611.159.7%n/aPharmaceuticals & Biotech
AXSM
US$236.950.7%131.1%US$11.4bUS$282.5117.257.0%n/aPharmaceuticals & Biotech
CORT
US$95.655.7%38.5%US$9.8bUS$106.00220.047.8%n/aPharmaceuticals & Biotech
LITE
US$837.562.8%740.7%US$59.6bUS$1,104.89148.456.5%n/aTech
NVDA
US$207.29-2.1%24.1%US$4.9tUS$302.8331.522.8%0.5%Semiconductors
RHM
€995.401.6%-43.2%€46.4b€1,697.8544.130.6%1.2%Capital Goods
CRDO
US$223.87-5.2%140.9%US$39.5bUS$279.2988.427.7%n/aSemiconductors
MOD
US$247.097.6%163.3%US$12.1bUS$340.86108.049.2%n/aCapital Goods
SAUD3
R$14.77-3.8%28.0%R$43.2bR$16.6276.443.7%5.5%Healthcare
600183
CN¥126.00-17.3%230.3%CN¥329.5bCN¥137.0877.928.6%1.3%Tech
MX1
AU$0.029-14.7%-55.4%AU$22.4mAU$0.151.3105.5%n/aHealthcare
AV1
AU$0.08-1.2%-33.3%AU$74.1mAU$0.177.8108.4%n/aSoftware
688192
CN¥60.86-10.0%-13.1%CN¥28.7bCN¥83.0031.7105.9%n/aPharmaceuticals & Biotech
688300
CN¥128.32-22.8%158.4%CN¥32.7bCN¥151.00102.937.0%0.4%Materials
456A
JP¥1,455.00-5.7%n/aJP¥135.7bn/a41.223.4%n/aRetail
501423
₹2,883.756.9%76.4%₹131.0b₹3,517.6778.133.7%0.1%Capital Goods
2480
HK$13.000.8%-38.4%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
543273
₹2,421.80-1.0%172.7%₹59.2b₹2,500.0075.153.9%n/aTransportation
1860
HK$10.974.9%30.1%HK$16.8bHK$18.2628.841.1%n/aMedia
Page 1 of 43